Biblio
Anti-tumor Efficacy and Safety of Unedited Autologous CD5.CAR T cells in Relapsed/Refractory Mature T-cell Lymphomas. Blood. 2023.
Mediport use as an acceptable standard for CAR T cell infusion. Front Immunol. 2023;14:1239132.
Targeted cellular therapy for treatment of relapsed or refractory leukemia. Best Pract Res Clin Haematol. 2023;36(3):101481.
.